Trump mandates vaccine schedule overhaul, splitting combination shots

The White House announced on Tuesday that President

The White House announced on Tuesday that President Trump has signed an executive order fundamentally reshaping the federal childhood immunization program, reducing the number of required vaccines and eliminating the combined measles-mumps-rubella (MMR) shot.

The new federal schedule, set to take effect within 90 days, will recommend protection against 11 diseases—a reduction of six from the current list of 17. Officials said the change aims to give parents more flexibility and to allow for a more individualized approach to pediatric care.

Under the revised framework, the MMR vaccine will no longer be administered as a single injection. Instead, separate doses for measles, mumps, and rubella will be made available, with health providers encouraged to space them out according to a child’s needs and family history.

Critics in the public health community immediately slamm…

Critics in the public health community immediately slammed the move, warning that breaking up combination vaccines could increase the number of office visits, delay full immunity, and create logistical hurdles for low-income families. Pediatricians’ groups also noted that the prior schedule was based on decades of safety and efficacy data.

Supporters, however, argue that the change respects parental choice and responds to concerns about vaccine ingredients and the timing of shots. The executive order also directs federal agencies to review all vaccine recommendations for potential conflicts of interest and to prioritize transparency in the approval process.

Federal health officials said the updated schedule will be published in the Federal Register, followed by a public comment period. States, which ultimately set their own school-entry vaccine requirements, are not obligated to adopt the new federal guidance, potentially setting up a patchwork of rules across the country.

The move marks the most significant shift in

The move marks the most significant shift in U.S. immunization policy in decades and is expected to face legal challenges from medical associations and patient advocacy groups in the coming weeks.